Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Balovaptan multiple-dose pharmacokinetics with and without itraconazole in healthy volunteers
NL-OMON46113Active, not recruiting
- Sponsor
- Roche
- Start
- Jun 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of balovaptan and itraconazole in Autism Spectrum Disorder (ASD), sponsored by Roche. Primary endpoint: Effect of itraconazole on balovaptan pharmacokinetics at steady state. Started Jun 2018; status: active, not recruiting.
02
Drugs
balovaptanitraconazole
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NL-OMON46113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46113.